Clinical Trials Browser

Completed × Interventional × Muscle Weakness × Clear all

NCT05451212 2025-11-10

Open-label Study to Evaluate the Safety of Various Dosing Regimens of MuSK-CAART for MuSK Myasthenia Gravis

Phase 1 Completed

Autoimmune Diseases, Immune System Diseases, Musculoskeletal Diseases, Myasthenia Gravis, Neuromuscular Diseases, Muscle Weakness

NCT05737160 2025-05-23

Study of Telitacicept in Generalized Myasthenia Gravis

Phase 3 Completed

Autoimmune Diseases, Myasthenia Gravis, Muscle Weakness

NCT04837248 2025-02-26

Design and Evaluation of the Effects of a Physical Therapy Program With Digital Support in Patients With Breast Cancer

Phase NA Completed

Breast Neoplasms, Depression, Fatigue, Lymphedema, Motor Activity, Muscle Weakness

NCT02873559 2024-05-29

PROGRESS

Phase 2/3 Completed

Motor Activity, Multiple Endocrine Neoplasia Type 1, Muscle Weakness

NCT04207359 2023-07-25

Effects of Creatine Supplementation in Breast Cancer Survivors

Phase NA Completed

Breast Neoplasms, Motor Activity, Muscular Atrophy, Muscle Weakness

NCT04755465 2022-05-31

Effects of NMES and Exercise in Hematological Cancer

Phase NA Completed

Other hematologic neoplasm

Muscle Weakness, Hematologic Neoplasms

NCT03194997 2021-06-14

Pilates and Dance to Breast Cancer Patients Undergoing Treatment

Phase NA Completed

Breast Neoplasms, Depression, Fatigue, Sleep Initiation and Maintenance Disorders, Lymphedema, Pain, Muscle Weakness, Sexual Dysfunctions, Psychological, Parasomnias

NCT03888248 2021-03-16

Whole-body Vibration in Children With Neurofibromatosis Type 1

Phase NA Completed

Neurofibromatosis 1, Muscle Weakness

NCT03789175 2020-12-08

Nicotinamide Riboside on Mitochondrial Function in Li-Fraumeni Syndrome

Phase 1/2 Completed

1 enrolled 7 charts

Neoplasms, Muscle Weakness

NCT02293239 2018-10-16

Effects of WB-EMS and Dietetic Treatment on Cancer Patients

Phase NA Completed

Cachexia, Muscular Atrophy, Neoplasms, Weight Loss, Muscle Weakness